Immunomodulatory effects of alpha interferon and thymostimulin in patients with neoplasias
- PMID: 7583935
- PMCID: PMC170190
- DOI: 10.1128/cdli.2.4.503-505.1995
Immunomodulatory effects of alpha interferon and thymostimulin in patients with neoplasias
Abstract
In this report, we have evaluated the immunological effects following administration of alpha interferon (IFN-alpha) in combination with thymostimulin (TP-1), as well as of IFN-alpha and TP-1 alone in patients with neoplasias who underwent surgery and were subsequently treated with conventional chemotherapy. Data suggest that the combination of IFN-alpha and TP-1 is the most effective in the up-regulation of some immune parameters such as the CD4(+)-CD8+ cell-dependent antibacterial activity. Since this immune function plays an important role in the host protection against different targets such as invading microorganisms and/or neoplastic cells, the administration of TP-1-IFN-alpha is advisable for patients with neoplasias under chemotherapy.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
